Means Investment CO. Inc. Has $2.69 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Means Investment CO. Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,600 shares of the healthcare conglomerate’s stock after selling 29 shares during the period. Means Investment CO. Inc.’s holdings in UnitedHealth Group were worth $2,689,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in UNH. International Assets Investment Management LLC lifted its holdings in UnitedHealth Group by 58.1% during the 1st quarter. International Assets Investment Management LLC now owns 7,062 shares of the healthcare conglomerate’s stock worth $3,458,000 after buying an additional 2,594 shares during the period. Unique Wealth LLC raised its stake in UnitedHealth Group by 30.8% during the first quarter. Unique Wealth LLC now owns 2,869 shares of the healthcare conglomerate’s stock worth $1,427,000 after buying an additional 676 shares during the last quarter. Salem Investment Counselors Inc. boosted its position in UnitedHealth Group by 7.8% during the first quarter. Salem Investment Counselors Inc. now owns 38,702 shares of the healthcare conglomerate’s stock valued at $19,146,000 after acquiring an additional 2,796 shares during the last quarter. Cooper Financial Group raised its position in shares of UnitedHealth Group by 8.0% in the 1st quarter. Cooper Financial Group now owns 2,239 shares of the healthcare conglomerate’s stock worth $1,108,000 after acquiring an additional 165 shares in the last quarter. Finally, Orser Capital Management LLC boosted its position in shares of UnitedHealth Group by 128.4% during the 1st quarter. Orser Capital Management LLC now owns 1,028 shares of the healthcare conglomerate’s stock valued at $509,000 after purchasing an additional 578 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the topic of several recent analyst reports. Barclays boosted their price target on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Stephens decreased their price target on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday. Cantor Fitzgerald increased their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research report on Wednesday. Argus increased their price target on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Finally, Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $615.58.

UnitedHealth Group Stock Up 0.6 %

UNH stock opened at $569.61 on Friday. The stock has a 50-day simple moving average of $584.42 and a two-hundred day simple moving average of $534.15. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $524.26 billion, a PE ratio of 34.82, a PEG ratio of 1.69 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the business posted $6.56 earnings per share. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.47%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.